Clinical trial
Impact of Regular Low-Frequency Hemoperfusion on Medium- to Long-Term Prognosis in Maintenance Dialysis Patients: A Real-World Single-Center Retrospective Study
NCT07348913 is registered in ClinicalTrials.gov with Yunfeng Xia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Regular Low-Frequency Hemoperfusion on Medium- to Long-Term Prognosis in Maintenance Dialysis Patients: A Real-World Single-Center Retrospective Study
- Lead sponsor
- Yunfeng Xia
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2015
- Completion date
- December 31, 2024
- Enrollment
- 879 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
maintenance dialysis patients, medium- to long-term prognosis, regular low-frequency hemoperfusion, retrospective study